廖俊星-研究成果

  1.  Liao CH, Huang YT, Chu FY, Lin TH, Hsueh PR. Lack of increase in time to blood culture positivity in a patient with persistent methicillin-resistant Staphylococcus aureus bacteremia predicts failure of antimicrobial therapy. J Microbiol Immunol Infect. 2008;41(4):355-7.

  2. Liao CH, Kung HC, Hsu GJ, Lu PL, Liu YC, Chen CM, et al. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods. Int J Antimicrob Agents. 2008;32 Suppl 3:S192-6.

  3. Liao CH, Liu LC, Huang YT, Teng LJ, Hsueh PR. Bacteremia caused by group G Streptococci, taiwan. Emerg Infect Dis. 2008;14(5):837-40.

  4. Liu CY, Huang YT, Liao CH, Hsueh PR. In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan. Antimicrob Agents Chemother. 2008;52(7):2677-9.

  5.  Liao CH, Lai CC, Hsu MS, Huang YT, Chu FY, Hsu HS, et al. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study. Clin Microbiol Infect. 2009;15(12):1119-25.

  6. Liao CH, Lai CC, Hsu MS, Chu FY, Wu MY, Huang YT, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar. Int J Antimicrob Agents. 2010;35(5):457-60.

  7. Hsu MS, Liao CH, Huang YT, Liu CY, Yang CJ, Kao KL, et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011;30(10):1271-8.

  8. Liao CH, Chang HT, Lai CC, Huang YT, Hsu MS, Liu CY, et al. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit. Diagn Microbiol Infect Dis. 2011;70(2):260-6.

  9. Liao CH, Huang YT, Lai CC, Chang CY, Chu FY, Hsu MS, et al. Klebsiella pneumoniae bacteremia and capsular serotypes, Taiwan. Emerg Infect Dis. 2011;17(6):1113-5.

  10. Truong-Bolduc QC, Bolduc GR, Okumura R, Celino B, Bevis J, Liao CH, et al. Implication of the NorB efflux pump in the adaptation of Staphylococcus aureus to growth at acid pH and in resistance to moxifloxacin. Antimicrob Agents Chemother. 2011;55(7):3214-9.

  11. Liao CH, Chuang CY, Huang YT, Lee PI, Hsueh PR. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008. J Infect. 2012;65(5):392-9.

  12. Liao CH, Ko WC, Lu JJ, Hsueh PR. Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan. Antimicrob Agents Chemother. 2012;56(7):3943-9.

  13. Truong-Bolduc QC, Hsing LC, Villet R, Bolduc GR, Estabrooks Z, Taguezem GF, et al. Reduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA. J Bacteriol. 2012;194(7):1823-34.

  14. Liao CH, Hsueh PR, Jacoby GA, Hooper DC. Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2013;68(12):2907-14.

  15. Tsai HY, Chen YH, Liao CH, Lu PL, Huang CH, Lu CT, et al. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010. Int J Antimicrob Agents. 2013;42(4):312-6.

  16. Liao CH, Huang YT, Chang CY, Hsu HS, Hsueh PR. Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections. Eur J Clin Microbiol Infect Dis. 2014;33(3):365-9.

  17. Liao CH, Huang YT, Tsai HY, Hsueh PR. In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis. Int J Antimicrob Agents. 2014;44(1):85-6.

  18. Hsu MS, Wu MY, Huang YT, Liao CH. Efficacy of chlorine dioxide disinfection to non-fermentative Gram-negative bacilli and non-tuberculous mycobacteria in a hospital water system. J Hosp Infect. 2016;93(1):22-8.

  19. Monarrez R, Wang Y, Fu Y, Liao CH, Okumura R, Braun MR, et al. Genes and Proteins Involved in qnrS1 Induction. Antimicrob Agents Chemother. 2018;62(9).

  20. Chen YC, Liao CH, Shen WT, Su C, Wu YC, Tsai MH, et al. Effective disinfection of airborne microbial contamination in hospital wards using a zero-valent nano-silver/TiO2 -chitosan composite. Indoor Air. 2019;29(3):439-49.

  21. Hsueh SC, Lee YJ, Huang YT, Liao CH, Tsuji M, Hsueh PR. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. J Antimicrob Chemother. 2019;74(2):380-6.

  22. Liao CH, Chen CS, Chen YC, Jiang NE, Farn CJ, Shen YS, et al. Vancomycin-loaded oxidized hyaluronic acid and adipic acid dihydrazide hydrogel: Bio-compatibility, drug release, antimicrobial activity, and biofilm model. J Microbiol Immunol Infect. 2020; 53(4):525-531.

  23. Liao CH, Lee NY, Tang HJ, Lee SS, Lin CF, Lu PL, et al. Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016. Infect Drug Resist. 2019;12:545-52.

  24. Liao CH, Chen WC, Li LH, Lin YT, Pan SY, Yang TC. AmpR of Stenotrophomonas maltophilia is involved instenobactin synthesis and enhanced b-lactam resistance in an iron-depleted condition. J Antimicrob Chemother. 2020; 75(12):3544-3551.

  25. Huang YT, Chen CS, Chen HA, Hsu HS, Liang MH, Chang MH, Liao CH*. Klebsiella pneumoniae bacteremia revisited: comparison between 2007 and 2017 prospective cohorts at a medical center in Taiwan. Journal of Infection. 2020; 81(5):753-757.

 

(更新日期:2020年12月22日)

 

 

22060 新北市板橋區南雅南路二段21號 TEL:(02)8966-7000 FAX:(02)8966-5967
預約掛號專線:(02)8966-9000 客服中心:(02)7738-2525